Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C11H20N3O14P3 |
Molecular Weight | 511.2095 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(O)(P(O)(O)=O)P(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@@H](O)[C@@H]1O)N2C=CC(N)=NC2=O
InChI
InChIKey=HUIKCRXUQCSUJS-ZLRZYOKSSA-N
InChI=1S/C11H20N3O14P3/c1-11(18,29(19,20)21)30(22,23)28-31(24,25)26-4-5-7(15)8(16)9(27-5)14-3-2-6(12)13-10(14)17/h2-3,5,7-9,15-16,18H,4H2,1H3,(H,22,23)(H,24,25)(H2,12,13,17)(H2,19,20,21)/t5-,7-,8+,9-,11?/m1/s1
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
332863-86-2
Created by
admin on Sat Dec 16 11:32:09 GMT 2023 , Edited by admin on Sat Dec 16 11:32:09 GMT 2023
|
PRIMARY | |||
|
MBC-11
Created by
admin on Sat Dec 16 11:32:09 GMT 2023 , Edited by admin on Sat Dec 16 11:32:09 GMT 2023
|
PRIMARY | Official Title: A Phase 1 Multicenter, Open-label, Dose-escalation Trial of MBC-11, an Etidronate-ara-C Conjugate in Patients With Malignant Tumors With Cancer-induced Bone Disease (CIBD); Purpose: This study evaluates MBC-11 (a conjugate of a bone-targeting vehicle (etidronate) and a cytostatic agent (ara-C) in patients with malignant tumors with CIBD. This is a first use in human. | ||
|
44463769
Created by
admin on Sat Dec 16 11:32:09 GMT 2023 , Edited by admin on Sat Dec 16 11:32:09 GMT 2023
|
PRIMARY | |||
|
4M53T688S5
Created by
admin on Sat Dec 16 11:32:09 GMT 2023 , Edited by admin on Sat Dec 16 11:32:09 GMT 2023
|
PRIMARY | |||
|
C125901
Created by
admin on Sat Dec 16 11:32:09 GMT 2023 , Edited by admin on Sat Dec 16 11:32:09 GMT 2023
|
PRIMARY |
ACTIVE MOIETY